Depression-like behavior in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome

Biology of Reproduction

Volumn 95, Issue 4, 2016, Pages

  Yu, Qiuxiao ^a   Hao, Shuxian ^a   Wang, Huamin ^a   Song, Xi ^a   Shen, Qiyang ^a   Kang, Jihong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Dehydroepiandrosterone; Depression; Monoamines; Polycystic ovary syndrome

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE; MONOAMINE; NORADRENALIN; PRASTERONE; SEROTONIN; SESAME SEED OIL; BIOGENIC AMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; FEMALE; FORCED SWIM TEST; HYPERANDROGENISM; MOUSE; NONHUMAN; OPEN FIELD TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TAIL SUSPENSION TEST; ADVERSE EFFECTS; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; HUMAN; LIPID DIET; METABOLISM; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PSYCHOLOGY; TISSUE DISTRIBUTION;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN; DEHYDROEPIANDROSTERONE; DEPRESSION; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; POLYCYSTIC OVARY SYNDROME; TISSUE DISTRIBUTION;

EID: 84995920279     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.116.142117     Document Type: Article

References (47)

1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551.
2. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7:219-231.
3. Li Y, Li Y, Yu Ng EH, Stener-Victorin E, Hou L, Wu T, Han F, Wu X. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril 2011; 96:452-458.
4. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2011; 26:2442-2451.
5. Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, de Avila MA, Nardi AE. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry 2010; 51:599-602.
6. Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011; 117:145-152.
7. Setji TL, Brown AJ. Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med 2014; 127:912-919.
8. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010; 93:2421-2423.
9. Klimczak D, Szlendak-Sauer K, Radowicki S. Depression in relation to biochemical parameters and age in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2015; 184:43-47.
10. Naqvi SH, Moore A, Bevilacqua K, Lathief S, Williams J, Naqvi N, Pal L. Predictors of depression in women with polycystic ovary syndrome. Arch Womens Ment Health 2015; 18:95-101.
11. Baumeister AA, Hawkins MF, Uzelac SM. The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci 2003; 12:207-220.
12. Ressler IB, Grayson BE, Ulrich-Lai YM, Seeley RJ. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab 2015; 308:E1076-E1084.
13. Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y, Kang J. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biol Reprod 2014; 91:127.
14. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977; 266:730-732.
15. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47:379-391.
16. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985; 85:367-370.
17. Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005; 29:571-625.
18. Rodrigues AL, da Silva GL, Mateussi AS, Fernandes ES, Miguel OG, Yunes RA, Calixto JB, Santos AR. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 2002; 70:1347-1358.
19. Marzotto M, Conforti A, Magnani P, Zanolin ME, Bellavite P. Effects of Ignatia amara in mouse behavioural models. Homeopathy 2012; 101: 57-67.
20. Lee KW, Westin L, Kim J, Chang JC, Oh YS, Amreen B, Gresack J, Flajolet M, Kim D, Aperia A, Kim Y, Greengard P. Alteration by p11 of mGluR5 localization regulates depression-like behaviors. Mol Psychiatry 2015; 20:1546-1556.
21. Michelsen KA, Prickaerts J, Steinbusch HW. The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease. Prog Brain Res 2008; 172:233-264.
22. Annagur BB, Kerimoglu OS, Tazegul A, Gunduz S, Gencoglu BB. Psychiatric comorbidity in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2015; 41:1229-1233.
23. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007; 87:1369-1376.
24. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009; 91:207-212.
25. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB. Gender differences in chronic major and double depression. J Affect Disord 2000; 60:1-11.
26. Milsom SR, Nair SM, Ogilvie CM, Stewart JM, Merry SN. Polycystic ovary syndrome and depression in New Zealand adolescents. J Pediatr Adolesc Gynecol 2013; 26:142-147.
27. Trent M, Austin SB, Rich M, Gordon CM. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005; 5:107-111.
28. Rahiminejad ME, Moaddab A, Rabiee S, Esna-Ashari F, Borzouei S, Hosseini SM. The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome. Iran J Reprod Med 2014; 12:811-816.
29. Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y, Kang J. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biol Reprod 2014; 91:127.
30. Finger BC, Dinan TG, Cryan JF. High-fat diet selectively protects against the effects of chronic social stress in the mouse. Neuroscience 2011; 192: 351-360.
31. Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond) 2013; 37:382-389.
32. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 2000; 25:765-771.
33. Jedel E, Gustafson D, Waern M, Sverrisdottir YB, Landen M, Janson PO, Labrie F, Ohlsson C, Stener-Victorin E. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome. Psychoneuroendocrinology 2011; 36: 1470-1479.
34. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004; 66:356-362.
35. Feng Y, Shao R, Weijdegard B, Wang T, Johansson J, Sun S, Wang W, Egecioglu E, Billig H, Stener-Victorin E. Effects of androgen and leptin on behavioral and cellular responses in female rats. Horm Behav 2011; 60: 427-438.
36. Hu M, Richard JE, Maliqueo M, Kokosar M, Fornes R, Benrick A, Jansson T, Ohlsson C, Wu X, Skibicka KP, Stener-Victorin E. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring. Proc Natl Acad Sci U S A 2015; 112: 14348-14353.
37. Dale E, Bang-Andersen B, Sanchez C. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharmacol 2015; 95:81-97.
38. Chang CY, Guo HR, Tsai WC, Yang KL, Lin LC, Cheng TJ. Subchronic arsenic exposure induces anxiety-like behaviors in normal mice and enhances depression-like behaviors in the chemically induced mouse model of depression. Biomed Res Int 2015; 2015:159015.
39. Kordjazy N, Haj-Mirzaian A, Amiri S, Ostadhadi S, Amini-Khoei H, Dehpour AR. Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test. Pharmacol Biochem Behav 2016; 141:1-9.
40. Shi X, Zhang L, Fu S, Li N. Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome. Arch Gynecol Obstet 2011; 284:773-778.
41. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T, Zhang WN, Pothuizen HH, Feldon J. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 2004; 28: 273-283.
42. Ho YC, Wang S. Adult neurogenesis is reduced in the dorsal hippocampus of rats displaying learned helplessness behavior. Neuroscience 2010; 171: 153-161.
43. Goeldner C, Reiss D, Kieffer BL, Ouagazzal AM. Endogenous nociceptin/orphanin-FQ in the dorsal hippocampus facilitates despair-related behavior. Hippocampus 2010; 20:911-916.
44. Hu Z, Cooper M, Crockett DP, Zhou R. Differentiation of the midbrain dopaminergic pathways during mouse development. J Comp Neurol 2004; 476:301-311.
45. Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, Kim SY, Adhikari A, Thompson KR, Andalman AS, Gunaydin LA, Witten IB, et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013; 493:537-541.
46. Park SK, Nguyen MD, Fischer A, Luke MP, Affar el B, Dieffenbach PB, Tseng HC, Shi Y, Tsai LH. Par-4 links dopamine signaling and depression. Cell 2005; 122:275-287.
47. Michaud JL. The developmental program of the hypothalamus and its disorders. Clin Genet 2001; 60:255-263.